Literature DB >> 12510775

Correlation of clinical and biological parameters with peritumoral edema in meningioma.

Sun Ha Paek1, Chae-Yong Kim, Young Yim Kim, In Ae Park, Min Seok Kim, Dong Gyu Kim, Hee-Won Jung.   

Abstract

Peritumoral edema (PTE) in meningioma occurs variably and can adversely affect the clinical course. Moreover, the etiology of PTE in meningioma is not well documented. To examine possible correlations with PTE, the authors investigated the clinical parameters and the expressions of vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMPs), and their inhibitors (TIMPs) in 20 meningiomas. The estimation of tumor volume (V(T)) and edema volume (V(E)) was done using Osiris software with magnetic resonance images and the edema index (EI) was calculated. The expression of VEGF, MMP, and TIMP were estimated in all 20 meningiomas by immunohistochemical staining, Western blotting, zymography, and laser densitometry. Tumor location was closely related with PTE. Meningiomas of the frontal lobe or the frontotemporal base had large PTEs, whereas those of the occipitoparietal lobe, posterior fossa or petroclivus were small. The level of VEGF expression bore correlation with the extent of PTE but not with histologic malignancy. MMP-2 and -9 were detected in 100% of meningiomas by zymography. The levels of MMP-9 were significantly elevated in moderate to severe edema (EI > 1.0) group (p < 0.05) whereas those of MMP-2 were elevated in minimal to mild edema (EI < 1.0) group. TIMP-1 and -2 were detected in 19 (95%) and 12 (60%) of meningiomas respectively and their presence had no significant correlations statistically with PTE between two groups (p = 0.190 and 0.089, respectively). Meningiomas with severe PTE expressed high levels of VEGF and MMP-9 and low levels of MMP-2. The expressions of MMP-2, -9, and TIMPs as well as VEGF in meningioma suggests that they are strongly related with the presence of PTE in meiningiomas, and that they might play the important role in the formation of PTE in meningiomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12510775     DOI: 10.1023/a:1021186401522

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Inhibitors of angiogenesis.

Authors:  M A Moses; R Langer
Journal:  Biotechnology (N Y)       Date:  1991-07

2.  Matrix metalloproteinases and their inhibitors in human pituitary tumors.

Authors:  E Beaulieu; Z Kachra; N Mousseau; L Delbecchi; J Hardy; R Béliveau
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

3.  Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis.

Authors:  T Mizoue; H Kawamoto; K Arita; A Tominaga; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.

Authors:  J Provias; K Claffey; L delAguila; N Lau; M Feldkamp; A Guha
Journal:  Neurosurgery       Date:  1997-05       Impact factor: 4.654

6.  Role of ischaemia in the genesis of oedema surrounding meningiomas assessed using magnetic resonance imaging and spectroscopy.

Authors:  Z Domingo; G Rowe; A M Blamire; T A Cadoux-Hudson
Journal:  Br J Neurosurg       Date:  1998-10       Impact factor: 1.596

Review 7.  Proteases and their inhibitors in human brain tumours: a review.

Authors:  H K Rooprai; D McCormick
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

8.  Peritumoral edema in meningiomas: microsurgical observations of different brain tumor interfaces related to computed tomography.

Authors:  F M Salpietro; C Alafaci; S Lucerna; D G Iacopino; C Todaro; F Tomasello
Journal:  Neurosurgery       Date:  1994-10       Impact factor: 4.654

9.  Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

Authors:  T Nakagawa; T Kubota; M Kabuto; K Sato; H Kawano; T Hayakawa; Y Okada
Journal:  J Neurosurg       Date:  1994-07       Impact factor: 5.115

10.  Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor.

Authors:  M Bitzer; H Opitz; J Popp; M Morgalla; A Gruber; E Heiss; K Voigt
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

View more
  21 in total

Review 1.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

2.  Peritumoral brain edema in meningiomas : correlation of radiologic and pathologic features.

Authors:  Byung-Won Kim; Min-Su Kim; Sang-Woo Kim; Chul-Hoon Chang; Oh-Lyong Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

Review 3.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

Review 4.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

5.  Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.

Authors:  Wuttipong Tirakotai; Hans-Dieter Mennel; Ilhan Celik; Dieter Hellwig; Helmut Bertalanffy; Thomas Riegel
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

6.  Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas.

Authors:  Kuan-Yin Tseng; Min-Huey Chung; Huey-Kang Sytwu; Horng-Mo Lee; Kuan-Yu Chen; Chen Chang; Chih-Kung Lin; Che-Hung Yen; Jia-Hong Chen; Gu-Jiun Lin; Hsin-I Ma; Yi-Shian Yeh; Da-Tong Ju; Ming-Ying Liu; Dueng-Yuan Hueng
Journal:  J Neurooncol       Date:  2010-04-29       Impact factor: 4.130

7.  MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

Authors:  V Barresi; E Vitarelli; G Tuccari; G Barresi
Journal:  J Neurooncol       Date:  2010-07-21       Impact factor: 4.130

8.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

9.  Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients.

Authors:  Nicole Lambertz; Nicolai El Hindy; Cordula Adler; Katharina Rump; Michael Adamzik; Kathy Keyvani; Agnes Bankfalvi; Winfried Siffert; I Erol Sandalcioglu; Hagen S Bachmann
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

10.  Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas.

Authors:  Takahiro Sakuma; Takao Nakagawa; Kazunori Ido; Hiroaki Takeuchi; Kazufumi Sato; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.